Tag: <span>Industry News</span>

Key Changes to Letters of Support in NSF SBIR Phase I Applications

πŸ“’ Important update: NSF SBIR Phase I applications no longer require Letters of Support! Focus on detailed technical merit, clear commercial potential, robust project plans, and team qualifications to strengthen your proposal. Stay ahead with these changes and boost your funding success! πŸš€βœ¨

Navigating the Latest NIH Omnibus Solicitations: Key Changes and Updates

πŸš€ NIH’s New SBIR/STTR Solicitations: Key Changes Unveiled! πŸš€

Discover the latest updates to the NIH Omnibus solicitations, including clinical trial requirements, streamlined submission processes, diverse funding mechanisms, and a renewed emphasis on diversity and inclusion. These changes are designed to enhance innovation and commercialization opportunities for small businesses. 🌟

Navigating the New NSF SBIR Phase I Project Description Template: Key Changes You Need to Know

πŸš€ The NSF SBIR Phase I Project Description template has new page lengths! πŸ“„ Intellectual Merit is now 7-10 pages, Broader Impacts remains 1-2 pages, Company and Team is 1-2 pages, and the new Commercialization Potential section is 1-3 pages. Stay ahead with these updates! 🌟